Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Mathew D, Marmarelis ME, Foley C, Bauml JM, et al. Science 2024;384:eadf1329.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mathew D, Marmarelis ME, Foley C, Bauml JM, et al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science 2024;384:eadf1329.
PMID: 38900877